Using genomic information to guide ibrutinib treatment decisions in chronic lymphocytic leukaemia: a cost-effectiveness analysis
<strong>Background:</strong> Genomic tests may improve the stratification of patients to receive new therapies in several disease areas. However, the use of expensive targeted therapies can impact on the costeffectiveness of these tests. This study presents an economic evaluation of geno...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Springer International Publishing
2017
|